MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Assessment of subclinical cerebellar involvement in progressive supranuclear palsy using SUIT based volumetric analysis

    A. Lenka, L. George, K.R. Jhunjhunwala, S.A. Pasha, S. Mangalore, J. Saini, R. Yadav, P.K. Pal (Bangalore, India)

    Objective: To explore the pattern of cerebellar atrophy if any, in patients with Progressive Supranuclear Palsy (PSP) using the SUIT (Spatially Unbiased atlas template for…
  • 2016 International Congress

    Dynamic dopamine transporter images are helpful for diagnosing parkinsonism

    K. Abe, K. Fukushima, T. Katuura, K. Kitajima, Y. Maeda, K. Hahiskawa, H. Yoshikawa (Nishinomiya, Japan)

    Objective: This study is aimed at introducing a new method to get Dopamine transporter (DAT) imaging simultaneously with regional cerebral flow (CBF) imaging. Background: DAT…
  • 2016 International Congress

    The role of the frontal lobe in complex walking among healthy older adults and patients with Parkinson’s disease: An fNIRS study

    A. Mirelman, I. Maidan, F. Nieuwhof, H. Bernad-Elazari, M.F. Reelick, B.R. Bloem, N. Giladi, J.E. Deutsch, J.A.H.R. Claassen, J.M. Hausdorff (Tel Aviv, Israel)

    Objective: To investigate the role of the frontal lobe during dual tasking and obstacle negotiation, in healthy older adults and patients with Parkinson's disease (PD).…
  • 2016 International Congress

    Behavioral and neuroimaging effects of LSVT-BIG and conventional physiotherapy in Parkinson’s disease

    F. Schaible, F. Schwartz, T. v. Eimeren, C. Eggers (Köln, Germany)

    Objective: To evaluate (1) the changes of non-motor symptoms such as depression, sleep disorders, pain and cognitive deficits in PD by practicing LSVT BIG therapy…
  • 2016 International Congress

    How does preprocessing affect estimation of causal information transfer in the human brain?

    I. Weber, E. Florin, F. Jung, M. von Papen, L. Timmermann (Cologne, Germany)

    Objective: To test the influence of common electrophysiological preprocessing on the estimation of transfer entropy. Background: Transfer entropy (TE) provides one possibility to study temporal…
  • 2016 International Congress

    Intraoperative localization of beta band and high-frequency oscillations within the subthalamic nucleus

    B.C.M. van Wijk, A. Pogosyan, T. Foltynie, M.I. Hariz, P. Limousin, L. Zrinzo, P. Brown, V. Litvak (London, United Kingdom)

    Objective: To investigate whether beta band activity (13-30Hz) and high-frequency oscillations (150-400Hz) arise from the same spatial location within the subthalamic nucleus (STN) of Parkinson's…
  • 2016 International Congress

    Memory compensation strategies in patients with Parkinson’s disease

    C.C. Walton, J.Y.Y. Szeto, L. Mowszowski, S.J.G. Lewis, S.L. Naismith (Sydney, Australia)

    Objective: To investigate the use of memory compensation strategies in Parkinson's disease. Background: Difficulty with memory is a particular cause of complaint in patients with…
  • 2016 International Congress

    Occurrence and pattern of cognitive deficits in prodromal Parkinson’s disease

    C. Pausch, J. Spiegel, F.A. Wollenweber, C. Bayer, U. Dillmann, K. Fassbender, S. Behnke (Homburg Saar, Germany)

    Objective: To assess a possible cognitive impairment and its specific profile in the prodromal phase of Parkinson's disease (PD). Background: Cognitive impairment is common in…
  • 2016 International Congress

    Cognition and amyloid biomarker status in non-demented patients with Parkinson’s disease patients (PD) with or without subjective cognitive decline (SCD)

    I. Liepelt-Scarfone, F. Klumpp, W. Maetzler, S. Nussbaum, M. Timmers, G. Salvadore, M. Albers, K. Michaelis, Z. Tkaczynska, J. Streffer, D. Berg (Tübingen, Germany)

    Objective: To compare the cognitive and Amyloid-beta 1-42 profile of non-demented Parkinson's disease patients (PD) reporting subjective cognitive decline (SCD) with or without concerns regarding…
  • 2016 International Congress

    Volition and action control in Parkinson’s disease patients with impulsive-compulsive behaviour disorders

    L. Ricciardi, P. Haggard, L. de Boer, C. Sorbera, M.P. Stenner, F. Morgante, M.J. Edwards (London, United Kingdom)

    Objective: We aimed to explore different aspects of action control, assessing reward-related behaviour, inhibition (externally and internally triggered) and sense of agency in Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 377
  • 378
  • 379
  • 380
  • 381
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley